Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Harmony Biosciences Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2022 / 12:30PM GMT
Release Date Price: $36.04 (-0.63%)
Tessa Thomas Romero
JPMorgan Chase & Co, Research Division - Associate

Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotechnology analysts here at JPMorgan. I'm joined by [Taylor Hamley] from the team. Our next presenting company is Harmony Biosciences, and presenting on behalf of the company, we have CEO, John Jacobs. (Operator Instructions)

With that, I will hand it over to John.

John Charles Jacobs
Harmony Biosciences Holdings, Inc. - President, CEO & Director

Thank you, Tessa, good morning, and good morning, everyone. I'd like to open the presentation by saying thank you very much for joining us and investing your time to learn more about our company, Harmony Biosciences, and happy new year to everyone. I'm also joined today by Sandip Kapadia, Harmony's CFO; Dr. Jeffrey Dayno, our Chief Medical Officer; and Jeffrey Dierks, our Chief Commercial Officer, who will be joining me for Q&A at the end of the formal presentation.

Next slide, please. Put up our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot